Title | Type | SJR | H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Frontiers in Medicinal Chemistry | book series | 0.226 Q3 | 7 | 29 | 27 | 4600 | 13 | 26 | 0.00 | 158.62 | |
2 | Critical Reviews in Toxicology | journal | 2.075 Q1 | 129 | 38 | 105 | 5576 | 694 | 99 | 4.47 | 146.74 | |
3 | Natural Product Reports | journal | 2.925 Q1 | 211 | 77 | 186 | 11182 | 1455 | 181 | 7.70 | 145.22 | |
4 | Current Drug Metabolism | journal | 1.223 Q1 | 122 | 90 | 255 | 12668 | 1277 | 245 | 4.44 | 140.76 | |
5 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.728 Q1 | 99 | 25 | 69 | 3489 | 351 | 64 | 4.20 | 139.56 | |
6 | Handbook of Experimental Pharmacology | journal | 1.728 Q1 | 110 | 155 | 390 | 19347 | 1316 | 371 | 4.11 | 124.82 | |
7 | Advances in Molecular Toxicology | book series | 0.166 Q3 | 18 | 8 | 14 | 942 | 10 | 12 | 0.88 | 117.75 | |
8 | Expert Opinion on Emerging Drugs | journal | 0.863 Q2 | 54 | 45 | 134 | 5224 | 386 | 134 | 3.00 | 116.09 | |
9 | Advanced Drug Delivery Reviews | journal | 4.230 Q1 | 366 | 139 | 364 | 15218 | 4422 | 315 | 12.18 | 109.48 | |
10 | Expert Opinion on Drug Discovery | journal | 0.463 Q3 | 84 | 92 | 303 | 9533 | 415 | 296 | 1.43 | 103.62 | |
11 | Expert Opinion on Therapeutic Targets | journal | 1.469 Q1 | 106 | 116 | 345 | 11796 | 1225 | 321 | 3.82 | 101.69 | |
12 | Expert Opinion on Drug Delivery | journal | 1.136 Q1 | 133 | 100 | 218 | 9913 | 758 | 204 | 3.20 | 99.13 | |
13 | Cellular and Molecular Life Sciences | journal | 3.995 Q1 | 261 | 299 | 843 | 28820 | 5655 | 839 | 6.45 | 96.39 | |
14 | Topics in Medicinal Chemistry | book series | 15 | 10 | 0 | 913 | 0 | 0 | 0.00 | 91.30 | ||
15 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.951 Q2 | 100 | 125 | 259 | 11138 | 976 | 253 | 3.57 | 89.10 | |
16 | Issues in Toxicology | book series | 0.197 Q3 | 18 | 18 | 51 | 1596 | 15 | 47 | 0.29 | 88.67 | |
17 | Neurotherapeutics | journal | 2.326 Q1 | 136 | 75 | 198 | 6608 | 1175 | 183 | 6.28 | 88.11 | |
18 | Expert Opinion on Therapeutic Patents | journal | 0.477 Q3 | 88 | 109 | 332 | 9508 | 405 | 321 | 1.21 | 87.23 | |
19 | Expert Review of Clinical Pharmacology | journal | 0.151 Q3 | 60 | 58 | 71 | 5034 | 32 | 61 | 0.45 | 86.79 | |
20 | Expert Opinion on Biological Therapy | journal | 1.137 Q1 | 102 | 141 | 454 | 11591 | 1569 | 448 | 3.57 | 82.21 | |
21 | BioDrugs | journal | 1.124 Q1 | 79 | 35 | 126 | 2782 | 442 | 117 | 4.24 | 79.49 | |
22 | Inflammation and Allergy - Drug Targets | journal | 0.911 Q2 | 55 | 51 | 97 | 3969 | 285 | 92 | 3.02 | 77.82 | |
23 | Biomarkers in Medicine | journal | 0.187 Q4 | 56 | 70 | 50 | 5373 | 29 | 41 | 0.58 | 76.76 | |
24 | Journal of International Peacekeeping | journal | 0.101 Q4 | 14 | 15 | 44 | 1145 | 8 | 42 | 0.15 | 76.33 | |
25 | Expert Opinion on Pharmacotherapy | journal | 0.613 Q2 | 93 | 271 | 794 | 20462 | 1915 | 773 | 2.52 | 75.51 | |
26 | Apoptosis : an international journal on programmed cell death | journal | 1.825 Q1 | 128 | 129 | 506 | 9689 | 2186 | 502 | 4.48 | 75.11 | |
27 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.589 Q2 | 30 | 28 | 78 | 2051 | 175 | 78 | 2.29 | 73.25 | |
28 | Expert Opinion on Investigational Drugs | journal | 1.251 Q1 | 117 | 165 | 481 | 12080 | 1956 | 449 | 4.54 | 73.21 | |
29 | Current Opinion in Investigational Drugs | journal | 1.276 Q1 | 83 | 136 | 371 | 9871 | 1308 | 339 | 3.66 | 72.58 | |
30 | Expert Review of Vaccines | journal | 1.278 Q1 | 105 | 156 | 310 | 11295 | 1142 | 276 | 3.97 | 72.40 | |
31 | Future Medicinal Chemistry | journal | 90 | 120 | 0 | 8645 | 0 | 0 | 0.00 | 72.04 | ||
32 | Clinical Pharmacokinetics | journal | 1.494 Q1 | 184 | 60 | 212 | 4237 | 1153 | 202 | 5.36 | 70.62 | |
33 | Molecular Diagnosis and Therapy | journal | 0.754 Q2 | 68 | 34 | 123 | 2398 | 314 | 117 | 2.54 | 70.53 | |
34 | Current Opinion in Molecular Therapeutics | journal | 1.249 Q1 | 67 | 77 | 212 | 5421 | 730 | 194 | 3.72 | 70.40 | |
35 | Side Effects of Drugs Annual | book series | 0.100 Q4 | 9 | 53 | 103 | 3707 | 2 | 53 | 0.02 | 69.94 | |
36 | Open Neuropsychopharmacology Journal | journal | 6 | 12 | 0 | 838 | 0 | 0 | 0.00 | 69.83 | ||
37 | Current Opinion in Drug Discovery and Development | journal | 1.722 Q1 | 85 | 73 | 215 | 5063 | 1028 | 197 | 5.07 | 69.36 | |
38 | Trends in Pharmacological Sciences | journal | 5.016 Q1 | 244 | 81 | 283 | 5573 | 2791 | 267 | 9.25 | 68.80 | |
39 | Progress in Medicinal Chemistry | journal | 0.746 Q2 | 38 | 14 | 21 | 961 | 36 | 17 | 1.92 | 68.64 | |
40 | Therapeutic Advances in Neurological Disorders | journal | 0.110 Q4 | 68 | 33 | 18 | 2252 | 9 | 13 | 0.50 | 68.24 | |
41 | Current Pharmaceutical Biotechnology | journal | 1.249 Q1 | 97 | 85 | 170 | 5699 | 606 | 150 | 3.88 | 67.05 | |
42 | Molecular Diversity | journal | 0.597 Q2 | 63 | 48 | 97 | 3137 | 295 | 94 | 2.05 | 65.35 | |
43 | Nano Today | journal | 4.977 Q1 | 175 | 48 | 88 | 3092 | 614 | 53 | 7.50 | 64.42 | |
44 | Inflammopharmacology | journal | 0.478 Q3 | 68 | 32 | 132 | 2045 | 220 | 127 | 1.77 | 63.91 | |
45 | Neuropsychopharmacology | journal | 3.590 Q1 | 249 | 255 | 835 | 16245 | 5588 | 800 | 6.85 | 63.71 | |
46 | Drugs of the Future | journal | 0.275 Q3 | 46 | 111 | 357 | 7063 | 245 | 356 | 0.59 | 63.63 | |
47 | HIV Therapy | journal | 14 | 60 | 0 | 3725 | 0 | 0 | 0.00 | 62.08 | ||
48 | Neuropharmacology | journal | 1.807 Q1 | 191 | 250 | 800 | 15008 | 3134 | 797 | 4.08 | 60.03 | |
49 | Psychopharmacology | journal | 2.178 Q1 | 214 | 389 | 1063 | 23283 | 4796 | 1025 | 4.23 | 59.85 | |
50 | CNS Neuroscience and Therapeutics | journal | 0.839 Q2 | 91 | 35 | 31 | 2080 | 84 | 30 | 2.71 | 59.43 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®